BIOMAT Database Logo BIOMAT Database Logo

Fosfomycin-resistant mutant of Escherichia coli. 1974

H C Wu, and P S Venkateswaran

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D010457 Peptidoglycan A structural polymer of the bacterial cell envelope consisting of sugars and amino acids which is responsible for both shape determination and cellular integrity under osmotic stress in virtually all bacteria. Murein,Pseudomurein
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D003090 Coliphages Viruses whose host is Escherichia coli. Escherichia coli Phages,Coliphage,Escherichia coli Phage,Phage, Escherichia coli,Phages, Escherichia coli
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D004988 Ethers, Cyclic Compounds of the general formula R-O-R arranged in a ring or crown formation. Cyclic Ether,Cyclic Ethers,Ether, Cyclic
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

H C Wu, and P S Venkateswaran
[Pathogenecity of fosfomycin-resistant strains isolated from Escherichia coli].
January 1999, The Japanese journal of antibiotics,
H C Wu, and P S Venkateswaran
Fosfomycin use in multi drug resistant uropathogenic Escherichia coli.
January 2015, Infectious disorders drug targets,
H C Wu, and P S Venkateswaran
Resensitization of Fosfomycin-Resistant Escherichia coli Using the CRISPR System.
August 2022, International journal of molecular sciences,
H C Wu, and P S Venkateswaran
New rifampin-resistant mutant of Escherichia coli.
May 1972, Journal of bacteriology,
H C Wu, and P S Venkateswaran
Characterization of a cinodine-resistant mutant of Escherichia coli.
November 1995, The Journal of antibiotics,
H C Wu, and P S Venkateswaran
Charactertization of spontaneous fosfomycin (phosphonomycin)-resistant cells of Escherichia coli B in vitro.
November 1975, The Journal of antibiotics,
H C Wu, and P S Venkateswaran
Emergence of fosfomycin-resistant isolates of Shiga-like toxin-producing Escherichia coli O26.
April 1999, Antimicrobial agents and chemotherapy,
H C Wu, and P S Venkateswaran
Molecular characterization of fosfomycin-resistant Escherichia coli urinary tract infection isolates from Australia.
September 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
H C Wu, and P S Venkateswaran
An Escherichia coli mutant resistant to 2-amino-hydroxyethylthiazole.
November 1967, Journal of biochemistry,
H C Wu, and P S Venkateswaran
Absence of fosfomycin resistance in gastrointestinal Escherichia coli following fosfomycin therapy.
September 2018, Journal of global antimicrobial resistance,
Copied contents to your clipboard!